Skip to main content
20 November 2026

LOTTE Biologics Completes New Manufacturing Plant in Incheon

LOTTE Biologics (CEOs James Park and Yooyeol Shin) held a completion ceremony for Plant 1 on the 18th at the event venue within the Songdo Bio Campus in Incheon.

CEO Yooyeol Shin also said in his congratulatory remarks, "The completion of the Songdo Bio Campus is meaningful not only because it marks the completion of a new production facility, but because it lays the groundwork for LOTTE Biologics to contribute to strengthening the large-scale manufacturing capabilities of Korea's bio industry." He emphasized, "Under our new vision, 'The New Benchmark for Next Generation CDMOs,' we will be a CDMO partner that walks alongside our customers over the long term, built on the quality, technology, and trust they can truly feel."

Dong-bin Shin, Chairman of LOTTE Group, said in his congratulatory remarks, "The bio business is LOTTE Group's future growth engine and a next-generation industry that will lead Korea's next generation. I hope Plant 1 of the Songdo Bio Campus will become an important turning point that goes beyond LOTTE Group's growth and raises the competitiveness of Korea's bio industry to the next level." He added, "Centered on Songdo, we will create quality jobs and nurture outstanding bio talent, while working closely with the government, related agencies, customers, and partners to contribute to the development of the domestic bio industry and the strengthening of national competitiveness."

slot gacor